Research
ReNU Syndrome was only identified as a distinct condition in 2024. This page brings together what’s known, what’s being investigated, and how families can be part of the science that will shape our understanding.
Our approach to research
ReNU Syndrome UK is committed to actively supporting research into the condition. We believe that better understanding leads to better care — for the individuals affected today, and for every family that will receive a diagnosis in the future.
We work alongside leading researchers and clinicians, share knowledge across our community, and help connect families with opportunities to contribute to studies that will define the future of ReNU Syndrome care.
Current research
ReNU Syndrome was first described in mid-2024, when two independent research groups identified variants in the RNU4-2 gene as the cause of a common neurodevelopmental syndrome. Since then, research has been focused on understanding how the condition affects individuals, its natural history over time, and possible therapeutic approaches.
Two of the researchers whose work has shaped our understanding of ReNU Syndrome are engaged with our charity:
Dr Nicky Whiffin
Researcher at the University of Oxford. Her lab’s work identifying RNU4-2 as a cause of neurodevelopmental disorders led directly to the description of ReNU Syndrome.
Dr Carlo Rinaldi
Clinician-scientist at the University of Oxford, whose research explores rare neurogenetic conditions and potential therapeutic approaches.
We are grateful for their continued engagement with our community and the wider ReNU family.
Clinical updates
Because ReNU Syndrome is a newly-identified condition, formal clinical guidelines do not yet exist. Clinicians and families are working together to build a shared understanding of how the condition affects individuals and how it can best be managed.
We will publish clinical updates here as new information becomes available — including emerging protocols, best-practice guidance, and updates from clinical teams working with people who have ReNU Syndrome.
We are not a medical service. Any information published here is for general awareness only and does not replace advice from your own clinical team.
Published papers
Peer-reviewed research on ReNU Syndrome has grown quickly since the condition was first described in mid-2024. Below are some of the most significant papers, arranged chronologically. All are freely available to read.
The foundational papers (2024)
One of the two papers that first identified ReNU Syndrome as a condition — describing how single changes in the RNU4-2 gene cause a common neurodevelopmental syndrome.
The companion paper to Chen et al., published almost simultaneously. Estimates that ReNU Syndrome may be one of the most common single-gene neurodevelopmental conditions.
A case report showing how re-analysing existing genome sequencing data can bring a diagnosis to a family who has been searching for one for years.
One of the earliest detailed clinical descriptions of ReNU Syndrome, based on eleven individuals — helping clinicians recognise the syndrome by its shared features.
A short accessible review setting out what ReNU Syndrome is, how it was discovered, and why it matters for the wider field of neurodevelopmental research.
Building the picture (2025)
Extends the science beyond ReNU Syndrome, showing that related genetic changes in other spliceosome components also cause neurodevelopmental disorders.
Broadens understanding of which specific genetic changes in RNU4-2 cause ReNU Syndrome — important for correctly interpreting new patient results.
A detailed clinical study of nine individuals — adding to the picture of how ReNU Syndrome affects people across age and severity.
2025 & beyond
Advanced laboratory work that helps clinicians and families interpret specific RNU4-2 genetic variants — including identifying a related but distinct recessive disorder.
Documents kidney-related features of ReNU Syndrome for the first time — widening the recognised clinical spectrum and suggesting kidney monitoring may be worthwhile.
Research news
We share updates on research developments as they happen — new papers, conference highlights, and news from the wider ReNU Syndrome research community.
Follow us on social media for the most up-to-date news, or check back here for longer-form updates.
Participation opportunities
One of the most powerful things a family can do to advance understanding of ReNU Syndrome is take part in research. Every participation helps build the picture of how the condition affects individuals across their lifetime.
Genomics England — the 100,000 Genomes Project
Many people with ReNU Syndrome have been diagnosed through the 100,000 Genomes Project, run by Genomics England. If you or a family member have not yet been genetically tested, or if a previous test came back inconclusive, Genomics England may be able to help.
Your GP or specialist can refer you into the NHS Genomic Medicine Service, which uses Genomics England’s infrastructure to sequence and analyse whole genomes.
Register your interest with us
As research develops, new opportunities for participation will emerge — from natural history studies to potential therapeutic trials. If you’d like us to keep you informed as these become available, please get in touch and we’ll add you to our research-updates list.
How you can help
Research into ReNU Syndrome relies on more than just laboratories. Every family, every clinician, and every supporter has a role to play.
Share your story
Each family’s experience helps build the picture of ReNU Syndrome. Sharing your story helps researchers, clinicians, and future families.
Take part in research
If participation opportunities are right for your family, register your interest and we’ll keep you informed as they emerge.
Support our work
Every donation helps us grow our community, raise awareness, and build the resources families need — laying the foundations for future work on research support and clinical partnerships.
Frequently asked questions
ReNU Syndrome is caused by a de novo (new) variant in the RNU4-2 gene — meaning it’s not usually inherited from a parent. It appears spontaneously.
Diagnosis is made through genetic testing, usually organised via a clinical geneticist. If you have concerns, speak to your GP or specialist about a referral to genetics services.
Because the condition was only identified in 2024, the exact number is still being established. Researchers estimate it may account for a significant proportion of previously undiagnosed neurodevelopmental disorders — potentially thousands of individuals worldwide.
Research is still in its early stages. Current care focuses on managing symptoms and supporting development. As the science develops, we will publish updates on any emerging therapeutic approaches.
Follow us on social media for regular updates, or contact us to be added to our research-updates list.
Have a question not answered here? Get in touch and we’ll do our best to help.
Every step forward matters
Research into ReNU Syndrome is at the very beginning of what will be a long journey. Every family, every study, every published paper takes us further forward.